BUSINESS INFORM JOURNAL.

УКР

ENG

Search:

REGISTRATION CERTIFICATE

KV #19905-9705 PR dated 02.04.2013.

FOUNDERS

RESEARCH CENTRE FOR INDUSTRIAL DEVELOPMENT PROBLEMS of NAS of Ukraine (KHARKIV, UKRAINE)

ROR

EDRPOU 05481984

According to the decision No. 802 of the National Council of Television and Radio Broadcasting of Ukraine dated 14.03.2024, is registered as a subject in the field of print media.
ID R30-03156

PUBLISHER

Liburkina L. M.

CATALOG

Social Innovations as a Factor in the Development of Pharmaceutical Companies’ Intellectual Capital
Posylkina O. V., Lisna A. G.

Posylkina, Olga V., and Lisna, Anastasiya G. (2026) “Social Innovations as a Factor in the Development of Pharmaceutical Companies’ Intellectual Capital.” Business Inform 3:594–603.
https://doi.org/10.32983/2222-4459-2026-3-594-603

Section: Management and Marketing

Article is written in Ukrainian
Downloads/views: 0

Download article (pdf) -

UDC 608.3+347.77

Abstract:
The aim of the article is to study the impact of social innovations on the development of the intellectual potential of pharmaceutical companies and to substantiate modern scientific and practical approaches to managing the development of intellectual capital through the improvement of social policy and the increase of social responsibility in the pharmaceutical business. It is noted that in a knowledge economy, social innovations become an effective tool for preserving the intellectual core of pharmaceutical companies. Without them, companies lose the ability to engage in efficient innovative activities and become uncompetitive. The factors that determine the transformation of pharmaceutical companies’ business models into a knowledge management-oriented model are analyzed. It is emphasized that the implementation of such a model requires a change in the social policy paradigm and an increase in the role of social responsibility in the pharmaceutical business. The contribution of foreign and domestic scientific schools to the study of the problem of the impact of social innovations on the development of companies’ intellectual capital has been studied. The experience of leading domestic and foreign pharmaceutical companies regarding the implementation of social innovations has been analyzed, and the results of this impact on the activities of pharmaceutical manufacturers and the development of structural elements of intellectual capital have been summarized. A matrix of the interrelationship between social innovations, the balanced scorecard (BSC) system, and the components of pharmaceutical companies’ intellectual capital has been constructed. A KPI system has been proposed that allows transforming social innovations into specific strategic indicators for managing the intellectual capital of drug manufacturing enterprises.

Keywords: social innovations; intellectual capital; pharmaceutical companies; intellectual capital management; balanced scorecard system; key performance indicators (KPI).

Tabl.: 4. Bibl.: 26.

Posylkina Olga V. – Doctor of Sciences (Pharmaceutics), Professor, Professor, Department of Management, Marketing and Quality Assurance in Pharmacy, National Pharmaceutical University (53 Hryhoriia Skovorody Str., Kharkіv, 61002, Ukraine)
Email: [email protected]
Lisna Anastasiya G. – Candidate of Sciences (Pharmaceutics), Associate Professor, Associate Professor, Department of Management, Marketing and Quality Assurance in Pharmacy, National Pharmaceutical University (53 Hryhoriia Skovorody Str., Kharkіv, 61002, Ukraine)
Email: [email protected]

List of references in article

Abeysekera I. (2021). Intellectual Capital and Knowledge Management Research towards Value Creation. From the Past to the Future. Journal of Risk Financial Management, 6(14). https://doi.org/10.3390/jrfm14060238
Becker G. S. (1993). Human Capital: A Theoretical and Empirical Analysis, with Special Reference to Education. (3rd ed.). Chicago: University of Chicago Press. http://dx.doi.org/10.7208/chicago/9780226041223.001.0001
Bratishko Yu. S., Tolochko V. M. & Zarichkova M. V. ta in. (2024). Sotsialni aspekty kadrovoho zabezpechennia aptechnykh zakladiv v umovakh sohodennia [Social aspects of staffing of pharmacy institutions in modern conditions]. «Sotsialna farmatsiia: stan, problemy ta perspektyvy»: materialy IX Mizhnarodnoi naukovo-praktychnoi konferentsii (m. Kharkiv, 25 kvitnia 2024 r.) ["Social Pharmacy: State, Problems and Prospects": materials of the IX International Scientific and Practical Conference (Kharkiv, April 25, 2024)] (pp. 220). Kharkiv: NFaU.
Bratishko Yu. S. & Posylkina O. V. (2021). Rozuminnia sutnosti sotsialnoi vidpovidalnosti farmatsevtychnoho biznesu ta neobkhidnosti yii derzhavnoho rehuliuvannia [Understanding the essence of corporate social responsibility of pharmaceutical business and the need for its state regulation]. Norwegian Journal of development of the International Science, 54, 58–66.
Bushuieva I. V. & Parchenko V. V. (2019). Rol sotsialnoi vidpovidalnosti u formuvanni stratehii rozvytku aptechnykh merezh [The role of social responsibility in forming the strategy of pharmacy networks development]. Farmatsevtychnyi zhurnal, 4, 15–22.
Edvinsson L. & Br?nig G. (2000). Der Skandia – Navigator. Aktiv Posten Wissens Kapital (pp. 35–131). https://doi.org/10.1007/978-3-322-82272-7_3
Edvinsson L. & Malone M. S. (1997). Intellectual Capital: Realizing Your Company’s True Value by Finding Its Hidden Brainpower. New York: Harper Business.
Grande S., Bertello A., De Bernardi P. & Ricciardi F. (2023). Enablers of explorative and exploitative intellectual capital in entrepreneurial ecosystems. Journal of Intellectual Capital, 1(24), 35–69. https://doi.org/10.1108/JIC-07-2021-0197
Kaplan R. S. & Norton D. P. (1996). The Balanced Scorecard: Translating Strategy into Action. Boston: Harvard Business Review Press.
Kendiukhov O. V. (2011). Teoretychni zasady orhanizatsiino-ekonomichnoho mekhanizmu upravlinnia intelektualnym kapitalom pidpryiemstva [Theoretical foundations of organizational and economic mechanism of enterprise intellectual capital management]. Visnyk ekonomiky transportu i promyslovosti, 36, 152–158. http://nbuv.gov.ua/UJRN/Vetp_2011_36_31
Khrapkina V. V. & Tyran O. V. (2022). Rozvytok korporatyvnoi sotsialnoi vidpovidalnosti u diialnosti suchasnoi ukrainskoi kompanii [Development of corporate social responsibility in the activities of a modern Ukrainian company]. Ekonomika ta pidpryiemnytstvo, 2, 119–124. https://doi.org/10.32840/1814-1161/2022-2-19
KNEU (2015). Sotsialna vidpovidalnist: navch. posib. / za zah. red. prof. A. M. Kolota [Social responsibility: tutorial / ed. by prof. A. M. Kolot]. Kyiv: KNEU.
NFaU (2019). Sotsialna farmatsiia v Ukraini: stan, problemy ta perspektyvy: monohrafiia / za red. A. A. Kotvitskoi [Social pharmacy in Ukraine: state, problems and prospects: monograph / ed. by A. A. Kotvitska]. Kharkiv: NFaU.
novartis.com. Ofitsiinyi sait farmatsevtychnoi kompanii «Novartis» v Ukraini [Official website of the pharmaceutical company "Novartis" in Ukraine]. https://www.novartis.com/ua-uk/
Novikova O. F. (2013). Formuvannia ta vykorystannia sotsialnoho potentsialu staloho rozvytku: kontseptualni pidkhody [Formation and use of social potential of sustainable development: conceptual approaches]. Upravlinnia ekonomikoiu: teoriia ta praktyka, 2013, 209–235. https://www.chumachenko-readings.org/download/2013/15-Novikova.pdf
Petrova I. L. (2013). Stratehichne upravlinnia liudskymy resursamy: navch. posib. [Strategic human resource management: tutorial]. Kyiv: KNEU.
pfizer.ua. Ofitsiinyi sait farmatsevtychnoi kompanii «Pfizer» v Ukraini [Official website of the pharmaceutical company "Pfizer" in Ukraine]. https://www.pfizer.ua/
Posylkina O. V. & Litvinova O. V. (2018). Upravlinnia intelektualnymy resursamy u farmatsii v umovakh innovatsiinoho rozvytku: monohrafiia [Intellectual resource management in pharmacy in terms of innovative development: monograph]. Kharkiv: NFaU.
sanofi.com. Ofitsiinyi sait farmatsevtychnoi kompanii «Sanofi» v Ukraini [Official website of the pharmaceutical company "Sanofi" in Ukraine]. https://www.sanofi.com/uk/ukraine
Schultz T. W. (1961). Investment in Human Capital. The American Economic Review, 1(51). https://la.utexas.edu/users/hcleaver/330T/350kPEESchultzInvestmentHumanCapital.pdf
Stewart T. A. (1998). Intellectual Capital: The New Wealth of Organizations. Crown Business.
Tkachenko N. O. (2018). Sotsialna vidpovidalnist u farmatsii: monohrafiia / za nauk. red. B. P. Hromovyka [Social responsibility in pharmacy: monograph / sci. ed. by B. P. Gromovyk]. Zaporizhzhia.
Ulrich D. (1996). Human Resource Champions: The Next Agenda for Adding Value and Delivering Results. Boston, MA: Harvard Business School Press.
Zarichkova M. V. (2016). Udoskonalennia sotsialnoho zakhystu spetsialistiv farmatsii shliakhom poperedzhennia yikh profesiinoho vyhorannia [Improvement of social protection of pharmacy specialists by preventing their professional burnout]. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 1, 38–43. https://dspace.nuph.edu.ua/bitstream/123456789/8816/1/38-43.pdf
Zhang X.-B., Duc T. Ph., Mutuc E. B. & Tsai F-S. (2021). Intellectual Capital and Financial Performance: Comparison With Financial and Pharmaceutical Industries in Vietnam. Frontiers in Psychology, 12. https://doi.org/10.3389/fpsyg.2021.595615
Zhytchenko H. O. (2017). Sutnist ta vyznachennia poniattia «intelektualnyi kapital» [Essence and definition of the concept of "intellectual capital"]. Ekonomika i suspilstvo, 12, 255–259. https://economyandsociety.in.ua/journals/12_ukr/43.pdf